DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lipsky AH, Lozier JN, Wiestner A.
Response to comment on incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.
Haematologica 2016;
101 (03) e124-e125
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.